Corbus Pharmaceuticals Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $981.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $981.00K.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.07M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $371.00K; Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed $371.00.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $3.41K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value as first filed |
|---|---|---|
| 2026-06-30 | $981.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $371.00K 10-Q · filed 2026-08-06 | $371.00 10-K · filed 2026-03-09 |
| 2025-09-30 | $3.41K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $312.00 10-Q · filed 2025-08-05 | |
| 2025-03-31 | $113.00 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $881.00 10-K · filed 2026-03-09 | $881.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $2.60M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $12.17M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $12.30M 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $20.22M 10-K · filed 2025-03-11 | $20.22M 10-K · filed 2024-03-12 |
| 2023-09-30 | $20.82M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $20.77M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $21.94M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $11.20M 10-K · filed 2023-03-07 | |
| 2022-09-30 | $10.98M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $10.82M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $10.37M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.53M 10-K · filed 2022-03-08 | |
| 2021-09-30 | $2.92M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.81M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $2.84M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $3.50M 10-K · filed 2021-03-15 | |
| 2020-09-30 | $3.60M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $54.04M 10-Q/A · filed 2020-08-31 | |
| 2020-03-31 | $20.98M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $20.08M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $17.43M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $28.32M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $28.46M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $22.51M 10-K · filed 2019-03-12 | |
| 2018-09-30 | $32.46M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $18.70M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $29.33M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $29.43M 10-K · filed 2018-03-12 | |
| 2017-09-30 | $29.99M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $25.49M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $36.75M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $39.19M 10-K · filed 2017-03-08 | |
| 2016-09-30 | $29.90M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $9.37M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $3.92M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $2.58M 10-K · filed 2016-03-28 | |
| 2015-09-30 | $2.65M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $7.95M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $7.06M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $7.69M 10-K · filed 2015-02-10 | |
| 2014-09-30 | $443.51K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |